Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Poly Medicure's Enterprise Value is ₹164,091 Mil.
Poly Medicure's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹4,458 Mil. Therefore, Poly Medicure's EV-to-EBIT ratio for today is 36.81.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Poly Medicure's Enterprise Value is ₹164,091 Mil.
Poly Medicure's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₹5,609 Mil. Therefore, Poly Medicure's EV-to-EBITDA ratio for today is 29.25.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Poly Medicure's Enterprise Value is ₹164,091 Mil.
Poly Medicure's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was ₹18,753 Mil. Therefore, Poly Medicure's EV-to-Revenue ratio for today is 8.75.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Poly Medicure's Enterprise Value is ₹164,091 Mil.
Poly Medicure's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil. Therefore, Poly Medicure's EV-to-FCF ratio for today is .
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Poly Medicure (NSE:POLYMED) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Poly Medicure's current Enterprise Value is ₹164,091 Mil.
Poly Medicure's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹4,458 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Poly Medicure's current Enterprise Value is ₹164,091 Mil.
Poly Medicure's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹5,609 Mil.
Poly Medicure's current Enterprise Value is ₹164,091 Mil.
Poly Medicure's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹18,753 Mil.
Poly Medicure's current Enterprise Value is ₹164,091 Mil.
Poly Medicure's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.
Poly Medicure's current Enterprise Value is ₹164,091 Mil.
Poly Medicure's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Poly Medicure Enterprise Value Related Terms
Poly Medicure Enterprise Value Historical Data
* Premium members only.
The historical data trend for Poly Medicure's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:POLYMED vs ISRG, BDX, MDLN: Enterprise Value Comparison
For the Medical Instruments & Supplies subindustry, Poly Medicure's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Poly Medicure Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Poly Medicure's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Poly Medicure's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Poly Medicure's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of ₹164,091 Mil mean?
Poly Medicure (NSE:POLYMED) has a Enterprise Value of ₹164,091 Mil as of Jul. 11, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Poly Medicure and its competitors.
Is Poly Medicure's Enterprise Value too high?
Poly Medicure's current Enterprise Value is ₹164,091 Mil. Overall, Poly Medicure has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Poly Medicure's Enterprise Value compare to ISRG and BDX?
Poly Medicure's Enterprise Value of ₹164,091 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Poly Medicure and its competitors. Poly Medicure's current Enterprise Value is ₹164,091 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poly Medicure stock overvalued right now?
Based on GuruFocus' analysis, Poly Medicure (NSE:POLYMED) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹2,317.28, compared to a current price of ₹1,668.30 — trading 28% below its estimated fair value. The current Enterprise Value is ₹164,091 Mil. Poly Medicure's overall GF Score™ is 91/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Poly Medicure (NSE:POLYMED), the current Enterprise Value is ₹164,091 Mil as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Poly Medicure (NSE:POLYMED) Overvalued in 2026?
Based on GuruFocus' analysis, Poly Medicure stock appears to be undervalued.
The current stock price of ₹1,668.30 is trading 28% below its estimated GF Value™ of ₹2,317.28.
GuruFocus considers Poly Medicure to be Modestly Undervalued.
Key valuation signals for NSE:POLYMED:
Enterprise Value: ₹164,091 Mil
GF Value™: ₹2,317.28 vs. price of ₹1,668.30 (28% below fair value)
No single metric tells the full story. See the NSE:POLYMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Poly Medicure Ltd engages in the manufacturing and sale of medical devices. It offers disposable medical devices for infusion therapy, blood management, gastroenterology, vascular access, surgery and wound drainage, anesthesia, and urology. Some of its products include Ventilator Circuit Combo Kits, Bain Circuits, Safety Introducer Needles, High-Pressure Vaccum Bottle-Triplet, Catheters, and others. Geographically, it derives a majority of its revenue from exports. The company operates under one segment namely Medical Devices.
91GF Score
Get the complete analysis for NSE:POLYMED
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:POLYMED has been successfully added to your 
